On February 20, 2024, enGene Holdings Inc. (NASDAQ: ENGN) completed previously announced private placement of 20 million of its common shares at US $10.00 for gross proceeds of US $200 million.
The financing included participation from new and existing investors, including Adage Capital Partners, LP, Blue Owl Healthcare Opportunities, Boxer Capital, Commodore Capital, Cormorant Asset Management, Deep Track Capital, Deerfield Management Company, Foresite Capital, Janus Henderson Investors, Logos Capital, Marshall Wace, Perceptive Advisors, Soleus Capital, Surveyor Capital, Venrock Healthcare Capital Partners, and a large investment management firm.
Lumira Ventures is the sole Canadian participant among enGene’s Canadian investors/shares which also include Fonds de solidarité FTQ, Northleaf Growth Fund, CTI Life Sciences Fund III funds, and Polar Multi-Strategy Master Fund/Polar Asset Management Partners Inc.
Lumira Ventures through two funds subscribed [Premium Contents, please Log In or Subscribe]